| Year |
Citation |
Score |
| 2024 |
Zingoni ZM, Okano JT, Ponce J, Dullie L, Blower S. Modeling travel-time to HIV treatment in Malawi: identifying rural-urban and wealth inequities. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 39313771 DOI: 10.1097/QAI.0000000000003539 |
0.316 |
|
| 2023 |
Song J, Okano JT, Ponce J, Busang L, Seipone K, Valdano E, Blower S. The role of migration networks in the development of Botswana's generalized HIV epidemic. Elife. 12. PMID 37665629 DOI: 10.7554/eLife.85435 |
0.332 |
|
| 2023 |
Song J, Okano JT, Ponce J, Busang L, Seipone K, Valdano E, Blower S. Population mobility and the development of Botswana's generalized HIV epidemic: a network analysis. Medrxiv : the Preprint Server For Health Sciences. PMID 36778345 DOI: 10.1101/2023.02.01.23285339 |
0.308 |
|
| 2022 |
Valdano E, Okano JT, Colizza V, Mitonga HK, Blower S. Use of mobile phone data in HIV epidemic control. The Lancet. Hiv. 9: e820-e821. PMID 36460021 DOI: 10.1016/S2352-3018(22)00332-0 |
0.311 |
|
| 2021 |
Okano JT, Busang L, Seipone K, Valdano E, Blower S. The potential impact of country-level migration networks on HIV epidemics in sub-Saharan Africa: the case of Botswana. The Lancet. Hiv. 8: e787-e792. PMID 34774183 DOI: 10.1016/S2352-3018(21)00267-8 |
0.311 |
|
| 2020 |
Palk L, Okano JT, Dullie L, Blower S. Travel time to health-care facilities, mode of transportation, and HIV elimination in Malawi: a geospatial modelling analysis. The Lancet. Global Health. 8: e1555-e1564. PMID 33220218 DOI: 10.1016/S2214-109X(20)30351-X |
0.353 |
|
| 2020 |
Okano JT, Sharp K, Valdano E, Palk L, Blower S. HIV transmission and source-sink dynamics in sub-Saharan Africa. The Lancet. Hiv. PMID 32066532 DOI: 10.1016/S2352-3018(19)30407-2 |
0.433 |
|
| 2019 |
Valdano E, Blower S. Universal Testing and Treatment for HIV Infection in Botswana. The New England Journal of Medicine. 381: 2180. PMID 31774970 DOI: 10.1056/NEJMc1911065#sa1 |
0.326 |
|
| 2019 |
Blower S, Okano JT. Precision public health and HIV in Africa. The Lancet. Infectious Diseases. 19: 1050-1052. PMID 31559952 DOI: 10.1016/S1473-3099(19)30474-8 |
0.407 |
|
| 2019 |
Okano JT, Blower S. New conceptual framework for tuberculosis transmission. The Lancet. Infectious Diseases. 19: 578. PMID 31122773 DOI: 10.1016/S1473-3099(19)30219-1 |
0.401 |
|
| 2018 |
Palk L, Gerstoft J, Obel N, Blower S. A modeling study of the Danish HIV epidemic in men who have sex with men: travel, pre-exposure prophylaxis and elimination. Scientific Reports. 8: 16003. PMID 30375426 DOI: 10.1038/S41598-018-33570-0 |
0.474 |
|
| 2018 |
Palk L, Blower S. Geographic variation in sexual behavior can explain geospatial heterogeneity in the severity of the HIV epidemic in Malawi. Bmc Medicine. 16: 22. PMID 29422096 DOI: 10.1186/S12916-018-1006-X |
0.45 |
|
| 2017 |
Okano JT, Coburn BJ, Blower S. Response to comment on "Using geospatial mapping to design HIV elimination strategies for sub-Saharan Africa". Science Translational Medicine. 9. PMID 28768805 DOI: 10.1126/Scitranslmed.Aan8494 |
0.421 |
|
| 2017 |
Coburn BJ, Okano JT, Blower S. Using geospatial mapping to design HIV elimination strategies for sub-Saharan Africa. Science Translational Medicine. 9. PMID 28356504 DOI: 10.1126/Scitranslmed.Aag0019 |
0.467 |
|
| 2016 |
Okano JT, Blower S. Sex-specific maps of HIV epidemics in sub-Saharan Africa. The Lancet. Infectious Diseases. 16: 1320-1322. PMID 27998582 DOI: 10.1016/S1473-3099(16)30451-0 |
0.401 |
|
| 2016 |
Okano JT, Gerstoft J, Obel N, Blower S. HIV elimination and population viral load. The Lancet. Hiv. 3: e507-e509. PMID 27788865 DOI: 10.1016/S2352-3018(16)30174-6 |
0.394 |
|
| 2016 |
Okano JT, Robbins D, Palk L, Gerstoft J, Obel N, Blower S. Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men. The Lancet. Infectious Diseases. PMID 27174504 DOI: 10.1016/S1473-3099(16)30022-6 |
0.472 |
|
| 2015 |
Palk L, Blower S. Mapping divided households and residency changes: the effect of couple separation on sexual behavior and risk of HIV infection. Scientific Reports. 5: 17598. PMID 26626310 DOI: 10.1038/Srep17598 |
0.415 |
|
| 2015 |
Supervie V, Barrett M, Kahn JS, Musuka G, Moeti TL, Busang L, Blower S. Corrigendum: Modeling dynamic interactions between pre-exposure prophylaxis interventions &treatment programs: predicting HIV transmission &resistance. Scientific Reports. 5: 13037. PMID 26384032 DOI: 10.1038/srep13037 |
0.308 |
|
| 2015 |
Palk L, Blower S. Brief report: Mobility and circular migration in Lesotho: implications for transmission, treatment, and control of a severe HIV epidemic. Journal of Acquired Immune Deficiency Syndromes (1999). 68: 604-8. PMID 25763787 DOI: 10.1097/Qai.0000000000000526 |
0.464 |
|
| 2015 |
Blower S, Palk L. Combination HIV prevention and the battle of the sexes. The Lancet. Infectious Diseases. 15: 261-3. PMID 25749218 DOI: 10.1016/S1473-3099(15)70037-X |
0.441 |
|
| 2014 |
Gerberry DJ, Wagner BG, Garcia-Lerma JG, Heneine W, Blower S. Using geospatial modelling to optimize the rollout of antiretroviral-based pre-exposure HIV interventions in Sub-Saharan Africa. Nature Communications. 5: 5454. PMID 25462707 DOI: 10.1038/Ncomms6454 |
0.403 |
|
| 2014 |
Blower S, Coburn BJ. Maximising the effect of combination HIV prevention in Kenya. Lancet (London, England). 384: 1426. PMID 25390322 DOI: 10.1016/S0140-6736(14)61859-6 |
0.423 |
|
| 2014 |
Okano JT, Blower S. Beware of using invalid transmission models to guide HIV health policy. The Lancet. Global Health. 2: e260. PMID 25103162 DOI: 10.1016/S2214-109X(14)70202-5 |
0.444 |
|
| 2014 |
Okano JT, Blower S. HIV treatment, preexposure prophylaxis, and drug resistance: reconciling conflicting predictions from mathematical models. The Journal of Infectious Diseases. 209: 163-4. PMID 24133183 DOI: 10.1093/Infdis/Jit544 |
0.397 |
|
| 2013 |
Coburn BJ, Blower S. Mapping HIV epidemics in sub-Saharan Africa with use of GPS data. The Lancet. Global Health. 1: e251-3. PMID 25104487 DOI: 10.1016/S2214-109X(13)70084-6 |
0.467 |
|
| 2013 |
Wagner BG, Coburn BJ, Blower S. Increasing survival time decreases the cost-effectiveness of using "test & treat'' to eliminate HIV epidemics. Mathematical Biosciences and Engineering : Mbe. 10: 1673-86. PMID 24245641 DOI: 10.3934/Mbe.2013.10.1673 |
0.44 |
|
| 2013 |
Coburn BJ, Okano JT, Blower S. Current drivers and geographic patterns of HIV in Lesotho: implications for treatment and prevention in Sub-Saharan Africa. Bmc Medicine. 11: 224. PMID 24131484 DOI: 10.1186/1741-7015-11-224 |
0.435 |
|
| 2012 |
Wagner BG, Blower S. Universal access to HIV treatment versus universal 'test and treat': transmission, drug resistance & treatment costs. Plos One. 7: e41212. PMID 22957012 DOI: 10.1371/Journal.Pone.0041212 |
0.397 |
|
| 2012 |
Coburn BJ, Blower S. A feasibility analysis of implementing interventions for discordant couples in 14 African countries: implications for epidemic control. Aids (London, England). 26: 1969-71. PMID 22824631 DOI: 10.1097/Qad.0B013E328357F783 |
0.433 |
|
| 2012 |
Supervie V, Blower S. Predicting effect of pre-exposure prophylaxis on HIV epidemics. Lancet (London, England). 379: 2423. PMID 22748579 DOI: 10.1016/S0140-6736(12)61057-5 |
0.35 |
|
| 2012 |
Go MH, Blower S. What impact will reducing concurrency have on decreasing the incidence of HIV in heterosexual populations? Sexually Transmitted Diseases. 39: 414-5. PMID 22588465 DOI: 10.1097/Olq.0B013E3182590628 |
0.487 |
|
| 2012 |
Wagner BG, Garcia-Lerma JG, Blower S. Factors limiting the transmission of HIV mutations conferring drug resistance: fitness costs and genetic bottlenecks. Scientific Reports. 2: 320. PMID 22432052 DOI: 10.1038/Srep00320 |
0.399 |
|
| 2011 |
Supervie V, Barrett M, Kahn JS, Musuka G, Moeti TL, Busang L, Blower S. Modeling dynamic interactions between pre-exposure prophylaxis interventions & treatment programs: predicting HIV transmission & resistance. Scientific Reports. 1: 185. PMID 22355700 DOI: 10.1038/Srep00185 |
0.43 |
|
| 2011 |
El-Sadr WM, Coburn BJ, Blower S. Modeling the impact on the HIV epidemic of treating discordant couples with antiretrovirals to prevent transmission. Aids (London, England). 25: 2295-9. PMID 21993304 DOI: 10.1097/Qad.0B013E32834C4C22 |
0.377 |
|
| 2011 |
Yasmin S, Gerberry DJ, Blower S. Human papillomavirus vaccination programs and human immunodeficiency virus epidemics. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 53: 845-6. PMID 21921228 DOI: 10.1093/Cid/Cir514 |
0.517 |
|
| 2011 |
Blower S, Go MH. The importance of including dynamic social networks when modeling epidemics of airborne infections: does increasing complexity increase accuracy? Bmc Medicine. 9: 88. PMID 21771292 DOI: 10.1186/1741-7015-9-88 |
0.302 |
|
| 2011 |
Coburn BJ, Gerberry DJ, Blower S. Quantification of the role of discordant couples in driving incidence of HIV in sub-Saharan Africa. The Lancet. Infectious Diseases. 11: 263-4. PMID 21453868 DOI: 10.1016/S1473-3099(11)70080-9 |
0.4 |
|
| 2010 |
Supervie V, Halima Y, Blower S. Assessing the impact of mass rape on the incidence of HIV in conflict-affected countries. Aids (London, England). 24: 2841-7. PMID 20859191 DOI: 10.1097/Qad.0B013E32833Fed78 |
0.461 |
|
| 2010 |
Wagner B, Blower S. Costs of eliminating HIV in South Africa have been underestimated. Lancet (London, England). 376: 953-4. PMID 20851250 DOI: 10.1016/S0140-6736(10)61442-0 |
0.418 |
|
| 2010 |
Supervie V, García-Lerma JG, Heneine W, Blower S. HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis. Proceedings of the National Academy of Sciences of the United States of America. 107: 12381-6. PMID 20616092 DOI: 10.1073/Pnas.1006061107 |
0.404 |
|
| 2010 |
Gerberry DJ, Blower S. Predicting the level of vaccine-induced cross-immunity necessary to eliminate HIV epidemics composed of multiple subtypes. Aids (London, England). 24: 1604-406. PMID 20539095 DOI: 10.1097/Qad.0B013E328337B973 |
0.305 |
|
| 2010 |
Coburn BJ, Blower S. A major HIV risk factor for young men who have sex with men is sex with older partners. Journal of Acquired Immune Deficiency Syndromes (1999). 54: 113-4. PMID 20335817 DOI: 10.1097/Qai.0B013E3181D43999 |
0.421 |
|
| 2010 |
Wagner BG, Kahn JS, Blower S. Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy? Aids (London, England). 24: 775-6. PMID 20177359 DOI: 10.1097/Qad.0B013E3283366782 |
0.437 |
|
| 2010 |
Smith RJ, Okano JT, Kahn JS, Bodine EN, Blower S. Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco. Science (New York, N.Y.). 327: 697-701. PMID 20075214 DOI: 10.1126/Science.1180556 |
0.401 |
|
| 2009 |
Wagner BG, Coburn BJ, Blower S. Calculating the potential for within-flight transmission of influenza A (H1N1). Bmc Medicine. 7: 81. PMID 20034378 DOI: 10.1186/1741-7015-7-81 |
0.303 |
|
| 2009 |
Breban R, Napravnik S, Kahn J, Blower S. Quantifying the treatment efficacy of reverse transcriptase inhibitors: new analyses of clinical data based on within-host modeling. Bmc Public Health. 9: S11. PMID 19922681 DOI: 10.1186/1471-2458-9-S1-S11 |
0.313 |
|
| 2009 |
Coburn BJ, Wagner BG, Blower S. Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). Bmc Medicine. 7: 30. PMID 19545404 DOI: 10.1186/1741-7015-7-30 |
0.319 |
|
| 2009 |
Wagner BG, Blower S. Voluntary universal testing and treatment is unlikely to lead to HIV elimination: a modeling analysis Nature Precedings. 4: 1-1. DOI: 10.1038/Npre.2009.3917.1 |
0.468 |
|
| 2008 |
Breban R, Supervie V, Okano JT, Vardavas R, Blower S. Is there any evidence that syphilis epidemics cycle? The Lancet. Infectious Diseases. 8: 577-81. PMID 18718441 DOI: 10.1016/S1473-3099(08)70203-2 |
0.335 |
|
| 2008 |
Wilson DP, Coplan PM, Wainberg MA, Blower SM. The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics. Proceedings of the National Academy of Sciences of the United States of America. 105: 9835-40. PMID 18606986 DOI: 10.1073/Pnas.0711813105 |
0.309 |
|
| 2008 |
Fenton KA, Breban R, Vardavas R, Okano JT, Martin T, Aral S, Blower S. Infectious syphilis in high-income settings in the 21st century. The Lancet. Infectious Diseases. 8: 244-53. PMID 18353265 DOI: 10.1016/S1473-3099(08)70065-3 |
0.368 |
|
| 2008 |
Blower S, Wilson DP, Coplan PM, Wainberg MA. Reply to Heise and Philpott: The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics Proceedings of the National Academy of Sciences of the United States of America. 105: E74. DOI: 10.1073/Pnas.0808272105 |
0.454 |
|
| 2007 |
Breban R, Vardavas R, Blower S. Mean-field analysis of an inductive reasoning game: application to influenza vaccination. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 76: 031127. PMID 17930219 DOI: 10.1103/Physreve.76.031127 |
0.315 |
|
| 2007 |
Schwartz EJ, Bodine EN, Blower S. Effectiveness and efficiency of imperfect therapeutic HSV-2 vaccines. Human Vaccines. 3: 231-8. PMID 17881889 DOI: 10.4161/Hv.4529 |
0.327 |
|
| 2007 |
Kajita E, Okano JT, Bodine EN, Layne SP, Blower S. Modelling an outbreak of an emerging pathogen. Nature Reviews. Microbiology. 5: 700-9. PMID 17703226 DOI: 10.1038/Nrmicro1660 |
0.318 |
|
| 2007 |
Blower S, Supervie V. Predicting the future of XDR tuberculosis. The Lancet. Infectious Diseases. 7: 443. PMID 17597567 DOI: 10.1016/S1473-3099(07)70143-3 |
0.319 |
|
| 2007 |
Wilson DP, Blower S. How far will we need to go to reach HIV-infected people in rural South Africa? Bmc Medicine. 5: 16. PMID 17577418 DOI: 10.1186/1741-7015-5-16 |
0.346 |
|
| 2007 |
Vardavas R, Breban R, Blower S. Can influenza epidemics be prevented by voluntary vaccination? Plos Computational Biology. 3: e85. PMID 17480117 DOI: 10.1371/Journal.Pcbi.0030085 |
0.305 |
|
| 2007 |
Crespi CM, Cumberland WG, Wald A, Corey L, Blower S. Longitudinal study of herpes simplex virus type 2 infection using viral dynamic modelling. Sexually Transmitted Infections. 83: 359-64. PMID 17475687 DOI: 10.1136/Sti.2006.022020 |
0.539 |
|
| 2007 |
Cohen MS, Gay C, Kashuba AD, Blower S, Paxton L. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Annals of Internal Medicine. 146: 591-601. PMID 17438318 DOI: 10.7326/0003-4819-146-8-200704170-00010 |
0.461 |
|
| 2007 |
Breban R, Vardavas R, Blower S. Theory versus data: how to calculate R0? Plos One. 2: e282. PMID 17356693 DOI: 10.1371/Journal.Pone.0000282 |
0.338 |
|
| 2007 |
Vardavas R, Blower S. The emergence of HIV transmitted resistance in Botswana: "when will the WHO detection threshold be exceeded?". Plos One. 2: e152. PMID 17225857 DOI: 10.1371/Journal.Pone.0000152 |
0.32 |
|
| 2007 |
Blower S. Response to continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?' [3] Aids. 21: 259-261. DOI: 10.1097/Qad.0B013E3280112231 |
0.389 |
|
| 2007 |
Breban R, Supervie V, Okano JT, Vardavas R, Blower S. The transmission dynamics of syphilis and the CDC's elimination plan Nature Precedings. 2: 1-1. DOI: 10.1038/Npre.2007.1373.1 |
0.34 |
|
| 2006 |
Breban R, McGowan I, Topaz C, Schwartz EJ, Anton P, Blower S. Modeling the potential impact of rectal microbicides to reduce hiv transmission in bathhouses. Mathematical Biosciences and Engineering : Mbe. 3: 459-66. PMID 20210374 DOI: 10.3934/Mbe.2006.3.459 |
0.475 |
|
| 2006 |
Breban R, Blower S. Role of parametric resonance in virological failure during HIV treatment interruption therapy. Lancet (London, England). 367: 1285-9. PMID 16631884 DOI: 10.1016/S0140-6736(06)68543-7 |
0.349 |
|
| 2006 |
Blower S, Bodine E, Kahn JO, McFarland W. Response to correspondence from Hastings et al. entitled 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?' [13] Aids. 20: 1356-1357. DOI: 10.1097/01.Aids.0000232258.04652.30 |
0.429 |
|
| 2005 |
Blower S. Modeling the potential public health impact of imperfect HIV vaccines. The Journal of Infectious Diseases. 192: 1494-5; author reply. PMID 16170769 DOI: 10.1086/444431 |
0.425 |
|
| 2005 |
Schwartz EJ, Blower S. Predicting the potential individual- and population-level effects of imperfect herpes simplex virus type 2 vaccines. The Journal of Infectious Diseases. 191: 1734-46. PMID 15838802 DOI: 10.1086/429299 |
0.34 |
|
| 2005 |
Crespi CM, Cumberland WG, Blower S. A queueing model for chronic recurrent conditions under panel observation. Biometrics. 61: 193-8. PMID 15737093 DOI: 10.1111/J.0006-341X.2005.040332.X |
0.51 |
|
| 2005 |
Blower S, Bodine E, Kahn J, McFarland W. The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. Aids (London, England). 19: 1-14. PMID 15627028 DOI: 10.1097/00002030-200501030-00001 |
0.448 |
|
| 2004 |
Ziv E, Daley CL, Blower S. Potential public health impact of new tuberculosis vaccines. Emerging Infectious Diseases. 10: 1529-35. PMID 15498152 DOI: 10.3201/Eid1009.030921 |
0.3 |
|
| 2004 |
Blower S, Ma L. Calculating the contribution of herpes simplex virus type 2 epidemics to increasing HIV incidence: treatment implications. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 39: S240-7. PMID 15494895 DOI: 10.1086/422361 |
0.484 |
|
| 2004 |
Blower S, Wald A, Gershengorn H, Wang F, Corey L. Targeting virological core groups: a new paradigm for controlling herpes simplex virus type 2 epidemics. The Journal of Infectious Diseases. 190: 1610-7. PMID 15478066 DOI: 10.1086/424850 |
0.344 |
|
| 2004 |
Blower S, Bernoulli D. An attempt at a new analysis of the mortality caused by smallpox and of the advantages of inoculation to prevent it. 1766. Reviews in Medical Virology. 14: 275-88. PMID 15334536 DOI: 10.1002/Rmv.443 |
0.317 |
|
| 2004 |
Blower S. Modelling the genital herpes epidemic. Herpes : the Journal of the Ihmf. 11: 138A-146A. PMID 15319083 |
0.323 |
|
| 2003 |
Blower S, Ma L, Farmer P, Koenig S. Predicting the impact of antiretrovirals in resource-poor settings: preventing HIV infections whilst controlling drug resistance. Current Drug Targets. Infectious Disorders. 3: 345-53. PMID 14754434 DOI: 10.2174/1568005033480999 |
0.498 |
|
| 2003 |
Blower S, Schwartz EJ, Mills J. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines. Aids Reviews. 5: 113-25. PMID 12876900 |
0.344 |
|
| 2002 |
Blower S, Volberding P. What can modeling tell us about the threat of antiviral drug resistance? Current Opinion in Infectious Diseases. 15: 609-14. PMID 12821838 DOI: 10.1097/00001432-200212000-00009 |
0.455 |
|
| 2002 |
Velasco-Hernandez JX, Gershengorn HB, Blower SM. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? The Lancet. Infectious Diseases. 2: 487-93. PMID 12150848 DOI: 10.1016/S1473-3099(02)00346-8 |
0.468 |
|
| 2001 |
Porco TC, Small PM, Blower SM. Amplification dynamics: predicting the effect of HIV on tuberculosis outbreaks. Journal of Acquired Immune Deficiency Syndromes (1999). 28: 437-44. PMID 11744831 |
0.337 |
|
| 2001 |
Blower S. Transmission of zidovudine resistant strains of HIV-1: the first wave. Aids (London, England). 15: 2317-8. PMID 11698706 DOI: 10.1097/00002030-200111230-00014 |
0.382 |
|
| 2001 |
Blower S. Calculating the consequences: HAART and risky sex. Aids (London, England). 15: 1309-10. PMID 11426077 DOI: 10.1097/00002030-200107060-00014 |
0.464 |
|
| 2001 |
Catania JA, Osmond D, Stall RD, Pollack L, Paul JP, Blower S, Binson D, Canchola JA, Mills TC, Fisher L, Choi KH, Porco T, Turner C, Blair J, Henne J, et al. The continuing HIV epidemic among men who have sex with men. American Journal of Public Health. 91: 907-14. PMID 11392933 DOI: 10.2105/Ajph.91.6.907 |
0.452 |
|
| 2000 |
Blower SM, Gershengorn HB, Grant RM. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science (New York, N.Y.). 287: 650-4. PMID 10649998 DOI: 10.1126/science.287.5453.650 |
0.36 |
|
| 2000 |
Ziv E, Daley C, Blower S. The Epidemic Impact of Therapy for Early Latent Tuberculosis Infection Journal of General Internal Medicine. 15: 12-12. DOI: 10.1046/J.1525-1497.2000.15200-49.X |
0.304 |
|
| 2000 |
Porco TC, Blower SM. HIV vaccines: The effect of the mode of action on the coexistence of HIV subtypes Mathematical Population Studies. 8: 205-229. |
0.326 |
|
| 1996 |
Service SK, Blower SM. Linked HIV epidemics in San Francisco. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 11: 311-3. PMID 8603271 |
0.34 |
|
| 1994 |
Blower SM, McLean AR. Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco Science. 265: 1451-1454. PMID 8073289 DOI: 10.1126/Science.8073289 |
0.368 |
|
| 1993 |
Blower S. Sex and sample size The Lancet. 341: 1023. PMID 8096902 DOI: 10.1016/0140-6736(93)91110-8 |
0.382 |
|
| 1992 |
Blower S, Medley G. Epidemiology, HIV and drugs: Mathematical models and data British Journal of Addiction. 87: 371-379. PMID 1559036 DOI: 10.1111/J.1360-0443.1992.Tb01938.X |
0.401 |
|
| 1991 |
Blower SM, Hartel D, Dowlatabadi H, Anderson RM, May RM. Drugs, sex and HIV: a mathematical model for New York City Philosophical Transactions - Royal Society of London, B. 331: 171-187. PMID 1674152 DOI: 10.1098/Rstb.1991.0006 |
0.333 |
|
| 1989 |
Blower S, Hartel D. HIV, drugs, and ecology Science. 246: 1236. PMID 2588002 DOI: 10.1126/Science.2588002 |
0.408 |
|
| Show low-probability matches. |